Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
COVID-19
92%
Multidimensional Prognostic Index
75%
Patients with COVID-19
75%
Internal Medicine
75%
SARS-CoV-2 Infection
52%
Hospitalized Older Patients
50%
Coronavirus Disease (COVID)
50%
Quality of Life Impact
50%
Quality of Life
50%
Remitting Seronegative Symmetrical Synovitis with pitting Edema
50%
RS3PE
50%
Retrospective Cohort
50%
Multicenter Cohort Study
50%
IgA Nephropathy (IgAN)
50%
Portugal
50%
Sepsis
35%
ICU Admission
35%
Noninvasive Ventilation
33%
Length of Stay
33%
Persistent Symptoms
33%
Pleural Effusion
33%
Arthralgia
33%
Pericardial Effusion
33%
Mechanical Ventilation
33%
Older Adults
33%
Intensive Care Unit
33%
Older Hospitalized Patients
29%
In-hospital Mortality
29%
Invasive Mechanical Ventilation
27%
Pneumocystis Jirovecii
25%
Indwelling Urinary Catheter
25%
Pneumocystosis
25%
Pneumonia
25%
Non-HIV
25%
Delirium
25%
Liver Injury
25%
Immunocompromised Patients
25%
Hospitalized Patients
25%
Observational Cohort Study
25%
European Studies
25%
Odds Ratio
25%
Hospitalized Older Adults
25%
Remdesivir Treatment
25%
Clinical Practice Guidelines
25%
Internal Medicine Wards
25%
Sjgren's Syndrome
25%
Geriatrics
25%
Vaccination
25%
Portuguese Society
25%
Mortality Risk
24%
Medicine and Dentistry
COVID-19
100%
Internal Medicine
75%
Infection
66%
Prevalence
55%
Cross Sectional Study
53%
SOFA Score
50%
Immunoglobulin A Nephropathy
50%
Edema
50%
Synovitis
50%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Quality of Life
50%
Artificial Respiration
47%
Pericardial Fluid
33%
Pleura Effusion
33%
Sepsis
33%
Arthralgia
33%
Intensive Care Unit
28%
Remdesivir
25%
Connective Tissue Disease
25%
Musculoskeletal Disease
25%
Immunocompromised Patient
25%
Human immunodeficiency virus
25%
Pneumocystosis
25%
Urinary System
25%
Hospital Mortality
22%
Awareness
22%
Glucocorticoid
16%
Recurrent Disease
16%
Invasive Ventilation
16%
Autoimmune Disease
16%
Non-Invasive Mechanical Ventilation
16%
Noninvasive Ventilation
16%
Serological Test
16%
Immunosuppressive Treatment
16%
Elderly Patient
16%
Arm
16%
Glomerulopathy
16%
Autoimmunity
16%
Chronic Kidney Disease
16%
Emergency Department
16%
Diseases
16%
Geriatric Assessment
13%
Non-Hodgkin Lymphoma
12%
Salivary Gland
12%
Systemic Disease
12%
Musculoskeletal Pain
12%
Xerostomia
12%
Early Diagnosis
12%
Lacrimal Gland
12%
Vaginal Dryness
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
80%
Infection
61%
Syndrome
58%
SARS Coronavirus
55%
Cross-Sectional Study
50%
Immunoglobulin A Nephropathy
50%
Edema
50%
Synovitis
50%
Diseases
43%
Coronavirinae
37%
Pericardial Effusion
33%
Pleura Effusion
33%
Arthralgia
33%
Remdesivir
25%
Delirium
25%
Cohort Study
25%
Liver Injury
25%
Glomerulopathy
16%
Autoimmune Disease
16%
Immunosuppressive Agent
16%
Glucocorticoid
16%
Chronic Kidney Failure
16%
Recurrent Disease
16%
Liver Enzyme
15%
Observational Study
12%
Hospital Infection
12%
Barthel Index
12%
Urine Retention
12%
Musculoskeletal Disease
12%
Congestive Heart Failure
12%
Health Status
12%
Chronic Obstructive Lung Disease
12%
Connective Tissue Disease
12%
Comorbidity
12%
Decubitus
12%
Asthma
12%
Hospital Mortality
8%
Frailty
7%
Rheumatic Disease
6%
Nonhodgkin Lymphoma
6%
Xerostomia
6%
Musculoskeletal Pain
6%
Systemic Disease
6%
Vaginal Dryness
6%
Dry Skin
6%
Enzyme Defect
5%
Sepsis
5%
Acute Kidney Failure
5%
Bilirubin
5%
Adult Respiratory Distress Syndrome
5%